Pancreatic Cancer Research

ResearcherXuzhou Medical CollegeActive in the last 2 years

Xi Yang

ORCID-verified (high confidence)As of 13 November 2026

Matched on ORCID iD 0000-0001-8630-5945; OpenAlex author ID A5100646461.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 0, last author 2)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
2
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

  1. Cancer-associated fibroblast-derived COL17A1 promotes gemcitabine resistance and tumorigenesis in pancreatic cancer cells by interacting with ACTN4. Last author DOI 10.1007/s12672-025-01825-8↗
  2. HMGA2 alleviates ferroptosis by promoting GPX4 expression in pancreatic cancer cells. Last author DOI 10.1038/s41419-024-06592-y↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Rongyu Shi · 1 shared paper, 2025
  2. Ziyang Luo · 1 shared paper, 2024

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.